Sizing solar-based mini-grids for growing electricity demand: insights from rural India

Mini-grids are a critical way to meet electricity access goals according to current and projected electricity demand of communities and so appropriately sizing them is essential to ensure their financial viability. However, estimation of demand for communities awaiting electricity access is uncertain and growth in demand along with the associated cost implications is rarely considered during estimation of mini-grid sizing. Using a case study of two rural communities in India, we assess the implications of demand growth on financial costs and performance of a mini-grid system consisting of solar photovoltaic (PV) panels and battery storage using two different system sizing approaches. We show a cost-saving potential of up to 12% when mini-grids are sized using a multi-stage approach where mini-grids gradually expand in several stages, rather than a single-stage optimisation approach. We perform a sensitivity analysis of the cost of the two sizing approaches by varying six key parameters: demand growth rate, logistics cost, system re-sizing frequency, likelihood of blackouts, solar PV and battery cost, and degradation rate. Of these, we find that system costs are most sensitive to variations in demand growth rates and cost decreases in solar PV and batteries. Our study shows that demand growth scenarios and choice of mini-grid sizing approaches have important financial and operational implications for the design of systems for rural electrification

Deorbit kit demonstration mission

In Low Earth Orbit, it is possible to use the ambient plasma and the geomagnetic field to exchange momentum with the Earth's magnetosphere without using propellant. A device that allows an efficient momentum exchange is the electrodynamic tether (EDT), a long conductor attached to the satellite. EDT technology has been demonstrated in several past missions, being the Plasma Motor Generator mission (NASA 1993) one of the most successful. Nevertheless, it is not until today that reality has imposed a strong need and a concrete use case for developing this technology. In March 2019, the European Commission project Electrodynamic Tether technology for PAssive Consumable-less deorbit Kit (E.T.PACK) started the design of a new generation EDT. After completing the design phase, the consortium manufactured and is currently testing a Deorbit Kit Demonstrator (DKD) breadboard based on EDT technology. The objective of E.T.PACK is to reach Technology Readiness Level equal to 4 by 2022. The DKD is a standalone 24-kg satellite with the objective to demonstrate the performances of the improved EDT solution and validate its ultra-compact deployment system. The DKD is composed of two modules that will separate in orbit extending a 500-m long tape-like tether. The deployed bare-Aluminium tether will capture electrons from the ambient plasma passively and the circuit will be closed with the ionospheric plasma by using an active electron emitter. E.T.PACK tether will take advantage of several novelties with respect to the mission flown in the past that will allow to optimize the system volume and mass. Once successful demonstrated in orbit, the team plans to develop a suite of EDT systems capable of deorbiting satellites between 200 and 1000 kg from an altitude up to 1200 km in a few months. The work presents the current design status of the de-orbit kit demonstrator breadboard, the simulations of the system deorbit performances and the development approach.This work was supported by the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No.828902 (3M€ E.T.PACK project) and No.101034874 (100K€ BMOM project). SG is supported by an Industrial Ph.D funded by Comunidad de Madrid (135K€ IND2019/TIC17198). The team has recently got 2.5M€ additional financial support from European Union (ETPACK-F project No. 101058166) for the manufacturing and qualification of the In Orbit Demonstration (IOD) by the end of 2025

México y Jalisco en la coyuntura : primer semestre de 1998

Análisis de coyuntura sobre los principales sucesos del primer semestre de 1997 en Jalisco, a nivel político, económico y social: la situación en el estado de los tres principales partidos políticos (PAN, PRI y PRD), la cuestión laboral, los derechos humanos y el problema de abastecimiento de agua en la zona metropolitana de Guadalajara.ITESO, A.C

Roadmap on Photovoltaic Absorber Materials for Sustainable Energy Conversion

Photovoltaics (PVs) are a critical technology for curbing growing levels of anthropogenic greenhouse gas emissions, and meeting increases in future demand for low-carbon electricity. In order to fulfil ambitions for net-zero carbon dioxide equivalent (CO2eq) emissions worldwide, the global cumulative capacity of solar PVs must increase by an order of magnitude from 0.9 TWp in 2021 to 8.5 TWp by 2050 according to the International Renewable Energy Agency, which is considered to be a highly conservative estimate. In 2020, the Henry Royce Institute brought together the UK PV community to discuss the critical technological and infrastructure challenges that need to be overcome to address the vast challenges in accelerating PV deployment. Herein, we examine the key developments in the global community, especially the progress made in the field since this earlier roadmap, bringing together experts primarily from the UK across the breadth of the photovoltaics community. The focus is both on the challenges in improving the efficiency, stability and levelized cost of electricity of current technologies for utility-scale PVs, as well as the fundamental questions in novel technologies that can have a significant impact on emerging markets, such as indoor PVs, space PVs, and agrivoltaics. We discuss challenges in advanced metrology and computational tools, as well as the growing synergies between PVs and solar fuels, and offer a perspective on the environmental sustainability of the PV industry. Through this roadmap, we emphasize promising pathways forward in both the short- and long-term, and for communities working on technologies across a range of maturity levels to learn from each other.Comment: 160 pages, 21 figure

De Raíz Diversa. Revista Especializada en Estudios Latinoamericanos (Vol. 1 no. 2 oct-dic 2014)

/Índice/ Autores que colaboran en este número > 9; Editorial > 13; /Artículos/ Oficio de historiador, ¿nuevo paradigma o positivismo? -Carlos Barros > 17; Desafíos de las Ciencias Sociales en América Latina. La experiencia en México. -Carlos Hernández Alcántara > 49; México y América Latina sujetos a la vulnerabilidad externa. -Arturo Huerta González > 69; Sertão Digital. Estudo de caso acerca do uso da Internet em Várzea Alegre, CE. -Maria Erica de Oliveira Lima, Priscila Dallva de Oliveira Falcã > 101; Pranchada infamante: Resistência ao castigo físico do soldado imperial na Guerra contra o Paraguai. -Mário Maestri > 125; Un proyecto de modernidad católico: el Ecuador de García Moreno. -Perla P. Valero Pacheco > 155 El mito del bilingüismo y la colonización lingüística en Paraguay. -Gaya Makaran > 183; Las primeras aproximaciones de la política exterior de Brasil en África y la utilización de las prácticas culturales de la población negra brasileña. -Mónica Velasco Molina > 213; /Reseñas/ Gustavo Ogarrio Badillo.Breve historia de la transición y el olvido. Una lectura de la democratización en América Latina. -Orlando Lima Rocha > 247; Carlos Oliva.Semiótica y capitalismo. Ensayos sobre la obra de Bolívar Echeverría. -Alejandro Fernando González Jiménez > 253; Eduardo Subirats.Mito y literatura: revalorar el simbolismo mitológico. -Carlos Pineda > 259; David Gómez Arredondo.Calibán en cuestión. Aproximaciones teóricas y filosóficas desde nuestra América. -Jaime Ortega Reyna > 265

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

Background Approximately 450 000 children are born with familial hypercholesterolaemia worldwide every year, yet only 2·1% of adults with familial hypercholesterolaemia were diagnosed before age 18 years via current diagnostic approaches, which are derived from observations in adults. We aimed to characterise children and adolescents with heterozygous familial hypercholesterolaemia (HeFH) and understand current approaches to the identification and management of familial hypercholesterolaemia to inform future public health strategies. Methods For this cross-sectional study, we assessed children and adolescents younger than 18 years with a clinical or genetic diagnosis of HeFH at the time of entry into the Familial Hypercholesterolaemia Studies Collaboration (FHSC) registry between Oct 1, 2015, and Jan 31, 2021. Data in the registry were collected from 55 regional or national registries in 48 countries. Diagnoses relying on self-reported history of familial hypercholesterolaemia and suspected secondary hypercholesterolaemia were excluded from the registry; people with untreated LDL cholesterol (LDL-C) of at least 13·0 mmol/L were excluded from this study. Data were assessed overall and by WHO region, World Bank country income status, age, diagnostic criteria, and index-case status. The main outcome of this study was to assess current identification and management of children and adolescents with familial hypercholesterolaemia. Findings Of 63 093 individuals in the FHSC registry, 11 848 (18·8%) were children or adolescents younger than 18 years with HeFH and were included in this study; 5756 (50·2%) of 11 476 included individuals were female and 5720 (49·8%) were male. Sex data were missing for 372 (3·1%) of 11 848 individuals. Median age at registry entry was 9·6 years (IQR 5·8–13·2). 10 099 (89·9%) of 11 235 included individuals had a final genetically confirmed diagnosis of familial hypercholesterolaemia and 1136 (10·1%) had a clinical diagnosis. Genetically confirmed diagnosis data or clinical diagnosis data were missing for 613 (5·2%) of 11 848 individuals. Genetic diagnosis was more common in children and adolescents from high-income countries (9427 [92·4%] of 10 202) than in children and adolescents from non-high-income countries (199 [48·0%] of 415). 3414 (31·6%) of 10 804 children or adolescents were index cases. Familial-hypercholesterolaemia-related physical signs, cardiovascular risk factors, and cardiovascular disease were uncommon, but were more common in non-high-income countries. 7557 (72·4%) of 10 428 included children or adolescents were not taking lipid-lowering medication (LLM) and had a median LDL-C of 5·00 mmol/L (IQR 4·05–6·08). Compared with genetic diagnosis, the use of unadapted clinical criteria intended for use in adults and reliant on more extreme phenotypes could result in 50–75% of children and adolescents with familial hypercholesterolaemia not being identified. Interpretation Clinical characteristics observed in adults with familial hypercholesterolaemia are uncommon in children and adolescents with familial hypercholesterolaemia, hence detection in this age group relies on measurement of LDL-C and genetic confirmation. Where genetic testing is unavailable, increased availability and use of LDL-C measurements in the first few years of life could help reduce the current gap between prevalence and detection, enabling increased use of combination LLM to reach recommended LDL-C targets early in life. Funding Pfizer, Amgen, Merck Sharp & Dohme, Sanofi–Aventis, Daiichi Sankyo, and Regeneron

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

Background: Approximately 450 000 children are born with familial hypercholesterolaemia worldwide every year, yet only 2·1% of adults with familial hypercholesterolaemia were diagnosed before age 18 years via current diagnostic approaches, which are derived from observations in adults. We aimed to characterise children and adolescents with heterozygous familial hypercholesterolaemia (HeFH) and understand current approaches to the identification and management of familial hypercholesterolaemia to inform future public health strategies. Methods: For this cross-sectional study, we assessed children and adolescents younger than 18 years with a clinical or genetic diagnosis of HeFH at the time of entry into the Familial Hypercholesterolaemia Studies Collaboration (FHSC) registry between Oct 1, 2015, and Jan 31, 2021. Data in the registry were collected from 55 regional or national registries in 48 countries. Diagnoses relying on self-reported history of familial hypercholesterolaemia and suspected secondary hypercholesterolaemia were excluded from the registry; people with untreated LDL cholesterol (LDL-C) of at least 13·0 mmol/L were excluded from this study. Data were assessed overall and by WHO region, World Bank country income status, age, diagnostic criteria, and index-case status. The main outcome of this study was to assess current identification and management of children and adolescents with familial hypercholesterolaemia. Findings: Of 63 093 individuals in the FHSC registry, 11 848 (18·8%) were children or adolescents younger than 18 years with HeFH and were included in this study; 5756 (50·2%) of 11 476 included individuals were female and 5720 (49·8%) were male. Sex data were missing for 372 (3·1%) of 11 848 individuals. Median age at registry entry was 9·6 years (IQR 5·8-13·2). 10 099 (89·9%) of 11 235 included individuals had a final genetically confirmed diagnosis of familial hypercholesterolaemia and 1136 (10·1%) had a clinical diagnosis. Genetically confirmed diagnosis data or clinical diagnosis data were missing for 613 (5·2%) of 11 848 individuals. Genetic diagnosis was more common in children and adolescents from high-income countries (9427 [92·4%] of 10 202) than in children and adolescents from non-high-income countries (199 [48·0%] of 415). 3414 (31·6%) of 10 804 children or adolescents were index cases. Familial-hypercholesterolaemia-related physical signs, cardiovascular risk factors, and cardiovascular disease were uncommon, but were more common in non-high-income countries. 7557 (72·4%) of 10 428 included children or adolescents were not taking lipid-lowering medication (LLM) and had a median LDL-C of 5·00 mmol/L (IQR 4·05-6·08). Compared with genetic diagnosis, the use of unadapted clinical criteria intended for use in adults and reliant on more extreme phenotypes could result in 50-75% of children and adolescents with familial hypercholesterolaemia not being identified. Interpretation: Clinical characteristics observed in adults with familial hypercholesterolaemia are uncommon in children and adolescents with familial hypercholesterolaemia, hence detection in this age group relies on measurement of LDL-C and genetic confirmation. Where genetic testing is unavailable, increased availability and use of LDL-C measurements in the first few years of life could help reduce the current gap between prevalence and detection, enabling increased use of combination LLM to reach recommended LDL-C targets early in life

Grid versus off-grid electricity access options: A review on the economic and environmental impacts

This research reviews the economic and environmental impacts of grid-extension and off-grid systems, to inform the appropriate electrification strategy for the current population without electricity access. The principal technologies reviewed are centralised conventional fossil-fuel grid-extension and off-grid systems mainly based on solar PV and batteries. It finds that relatively few studies explicitly compare grid-extension electricity costs against off-grid systems costs and that there is a lack of consistency in the methodologies used to determine the least-cost solution. Nevertheless, the studies reviewed show a range of around $0.2–1.4/kWh for off-grid electricity access, compared to a range of below$0.1/kWh to more than $8/kWh for grid access, pointing to a number of cases in which off-grid access may already be the more cost-effective option. Existing literature on the environmental impacts primarily focuses on greenhouse gas emissions from electricity generation, with off-grid (solar PV and storage) systems’ emissions in the range of 50–130 gCO2-eq/kWh and grid generation from close to 0 gCO2-eq/kWh (for renewables and nuclear sources) to over 1,000 gCO2-eq/kWh (for coal). Emissions impacts stemming from transmission and distribution grids suggest a range of 0–30 gCO2-eq/kWh. Assessments of other environmental impacts such as water use, land use, biodiversity and e-waste are often absent in studies, whilst few studies explicitly compare the environmental impacts of grid versus off-grid systems. Further research should focus on comparing the costs of electricity access options using consistent metrics, expanding the scope of environmental impacts analysis, and integrating environmental and economic impacts into a comprehensive sustainability assessment of different options